Efficacy and safety of canakinumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: A single-centre observational study.
Mod Rheumatol
; 32(4): 797-802, 2022 Jul 01.
Article
in En
| MEDLINE
| ID: mdl-34897516
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Familial Mediterranean Fever
/
Antibodies, Monoclonal, Humanized
Type of study:
Diagnostic_studies
/
Observational_studies
Limits:
Humans
Language:
En
Journal:
Mod Rheumatol
Year:
2022
Document type:
Article
Affiliation country: